SCHEMBL2652224

SCHEMBL2652224

O=C(O)CCNC(=O)c1ccc(OCCCc2ccc(-c3ccc(C(F)(F)F)cc3)nc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GCGR P47871 10/20 0.51
GIPR P48546 6/20 0.51
GCG P01275 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
DGAT1 O75907 2/20 0.48
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
EPHX2 P34913 1/20 0.44
PPARA Q07869 1/20 0.44
FFAR1 O14842 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2C9 P11712 1/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652203 0.97 GCGR (0.50) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2651583 0.96 GCGR (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2652475 0.96 GCGR (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2651638 0.96 GCGR (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2653041 0.96 GCGR (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2653120 0.95 GCGR (0.51) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2650317 0.92 GCG (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2662329 0.91 MEN1 (0.49) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2654456 0.91 GCG (0.50) GCGRGIPRGCGMEN1KMT2A
SCHEMBL2655011 0.91 GCG (0.50) GCGRGIPRGCGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP claimed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO claimed
EP-1758859-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005118542-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed